These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
205 related articles for article (PubMed ID: 8788994)
1. Synthetic peptide-based enzyme-linked immunosorbent assay for serodiagnosis of visceral leishmaniasis. Fargeas C; Hommel M; Maingon R; Dourado C; Monsigny M; Mayer R J Clin Microbiol; 1996 Feb; 34(2):241-8. PubMed ID: 8788994 [TBL] [Abstract][Full Text] [Related]
2. Serodiagnosis of Chagas' disease by enzyme-linked immunosorbent assay using two synthetic peptides as antigens. Peralta JM; Teixeira MG; Shreffler WG; Pereira JB; Burns JM; Sleath PR; Reed SG J Clin Microbiol; 1994 Apr; 32(4):971-4. PubMed ID: 8027352 [TBL] [Abstract][Full Text] [Related]
3. Serodiagnosis of cutaneous leishmaniasis: assessment of an enzyme-linked immunosorbent assay using a peptide sequence from gene B protein. Jensen AT; Gaafar A; Ismail A; Christensen CB; Kemp M; Hassan AM; Kharazmi A; Theander TG Am J Trop Med Hyg; 1996 Nov; 55(5):490-5. PubMed ID: 8940979 [TBL] [Abstract][Full Text] [Related]
4. Antibody response against a Leishmania donovani amastigote-stage-specific protein in patients with visceral leishmaniasis. Ghedin E; Zhang WW; Charest H; Sundar S; Kenney RT; Matlashewski G Clin Diagn Lab Immunol; 1997 Sep; 4(5):530-5. PubMed ID: 9302200 [TBL] [Abstract][Full Text] [Related]
5. Application of an improved method for the recombinant k 39 enzyme-linked immunosorbent assay to detect visceral leishmaniasis disease and infection in Bangladesh. Kurkjian KM; Vaz LE; Haque R; Cetre-Sossah C; Akhter S; Roy S; Steurer F; Amann J; Ali M; Chowdhury R; Wagatsuma Y; Williamson J; Crawford S; Breiman RF; Maguire JH; Bern C; Secor WE Clin Diagn Lab Immunol; 2005 Dec; 12(12):1410-5. PubMed ID: 16339064 [TBL] [Abstract][Full Text] [Related]
6. rKLO8, a novel Leishmania donovani - derived recombinant immunodominant protein for sensitive detection of visceral leishmaniasis in Sudan. Abass E; Bollig N; Reinhard K; Camara B; Mansour D; Visekruna A; Lohoff M; Steinhoff U PLoS Negl Trop Dis; 2013; 7(7):e2322. PubMed ID: 23875052 [TBL] [Abstract][Full Text] [Related]
7. Evaluation of enzyme-linked immunosorbent assay for diagnosis of post-kala-azar dermal leishmaniasis with crude or recombinant k39 antigen. Salotra P; Sreenivas G; Nasim AA; Subba Raju BV; Ramesh V Clin Diagn Lab Immunol; 2002 Mar; 9(2):370-3. PubMed ID: 11874880 [TBL] [Abstract][Full Text] [Related]
8. Optimisation of an ELISA for the serodiagnosis of visceral leishmaniasis using in vitro derived promastigote antigens. Rajasekariah GH; Ryan JR; Hillier SR; Yi LP; Stiteler JM; Cui L; Smithyman AM; Martin SK J Immunol Methods; 2001 Jun; 252(1-2):105-19. PubMed ID: 11334970 [TBL] [Abstract][Full Text] [Related]
9. Short report: production of recombinant kinesin-related protein of Leishmania donovani and its application in the serodiagnosis of visceral leishmaniasis. Takagi H; Islam MZ; Itoh M; Islam AU; Saifuddin Ekram AR; Hussain SM; Hashiguchi Y; Kimura E Am J Trop Med Hyg; 2007 May; 76(5):902-5. PubMed ID: 17488913 [TBL] [Abstract][Full Text] [Related]
10. Comparative evaluation of enzyme-linked immunosorbent assays based on crude and recombinant leishmanial antigens for serodiagnosis of symptomatic and asymptomatic Leishmania infantum visceral infections in dogs. Porrozzi R; Santos da Costa MV; Teva A; Falqueto A; Ferreira AL; dos Santos CD; Fernandes AP; Gazzinelli RT; Campos-Neto A; Grimaldi G Clin Vaccine Immunol; 2007 May; 14(5):544-8. PubMed ID: 17314229 [TBL] [Abstract][Full Text] [Related]
11. A panel of recombinant Roberts AJ; Ong HB; Clare S; Brandt C; Harcourt K; Takele Y; Ghosh P; Toepp A; Waugh M; Matano D; Färnert A; Adams E; Moreno J; Mbuchi M; Petersen C; Mondal D; Kropf P; Wright GJ mBio; 2024 May; 15(5):e0085924. PubMed ID: 38639536 [TBL] [Abstract][Full Text] [Related]
12. Antigenicity of phage clones and their synthetic peptides for the serodiagnosis of canine and human visceral leishmaniasis. Costa LE; Salles BCS; Santos TTO; Ramos FF; Lima MP; Lima MIS; Portela ÁSB; Chávez-Fumagalli MA; Duarte MC; Menezes-Souza D; Machado-de-Ávila RA; Silveira JAG; Magalhães-Soares DF; Goulart LR; Coelho EAF Microb Pathog; 2017 Sep; 110():14-22. PubMed ID: 28629727 [TBL] [Abstract][Full Text] [Related]
14. Predicting kala-azar disease manifestations in asymptomatic patients with latent Leishmania donovani infection by detection of antibody against recombinant K39 antigen. Singh S; Kumari V; Singh N Clin Diagn Lab Immunol; 2002 May; 9(3):568-72. PubMed ID: 11986261 [TBL] [Abstract][Full Text] [Related]
15. Immunoglobulin subclass distribution and diagnostic value of Leishmania donovani antigen-specific immunoglobulin G3 in Indian kala-azar patients. Anam K; Afrin F; Banerjee D; Pramanik N; Guha SK; Goswami RP; Gupta PN; Saha SK; Ali N Clin Diagn Lab Immunol; 1999 Mar; 6(2):231-5. PubMed ID: 10066659 [TBL] [Abstract][Full Text] [Related]
16. Serodiagnosis of Leishmania donovani infections: assessment of enzyme-linked immunosorbent assays using recombinant L. donovani gene B protein (GBP) and a peptide sequence of L. donovani GBP. Jensen AT; Gasim S; Moller T; Ismail A; Gaafar A; Kemp M; el Hassan AM; Kharazmi A; Alce TM; Smith DF; Theander TG Trans R Soc Trop Med Hyg; 1999; 93(2):157-60. PubMed ID: 10450438 [TBL] [Abstract][Full Text] [Related]
17. Evaluation of an enzyme-linked immunosorbent assay based on crude Leishmania histone proteins for serodiagnosis of human infantile visceral leishmaniasis. Lakhal S; Mekki S; Ben-Abda I; Mousli M; Amri F; Aoun K; Bouratbine A Clin Vaccine Immunol; 2012 Sep; 19(9):1487-91. PubMed ID: 22815147 [TBL] [Abstract][Full Text] [Related]